Biography

Dr. Francisco Fuentes is a board-certified Physician and Professor at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth Houston). Dr. Fuentes is The Theodore & Maureen O’Driscoll-Levy Professor and is Director of the Cardiac Rehabilitation Program and Cardiology Fellowship Program, underscoring his excellence as a clinician and educator.

Dr. Fuentes is also a recognized health educator in the community, and routinely volunteers at the San Jose Clinic. He received the Herbert L. and Margaret W. DuPont Master Clinical Teaching Award. He was named Texas Super Doctor by Texas Monthly and Top Doctors for Women—Cardiology by H. Texas Magazine and was presented with a Special Congressional Recognition by Congressman Al Green in Honor of Outstanding Dedication to Healthcare, Education and Community Service. He also was honored by The American Heart Association for Numerous Contributions to the Field of Cardiovascular Medicine and the Hispanic Community.

He received the Benjy F. Brooks M.D. Award from The University of Texas Medical School at Houston for outstanding clinical faculty.

 

Board Certifications

  • Diplomate ABIM, Critical Care Medicine
  • Diplomate ABIM, Cardiovascular Disease
  • Diplomate American Board of Internal Medicine
  • Federal Licensing Examination (FLEX)
  • ECFMG
  • Diplomate in Cardiovascular Disease, University of Barcelona Barcelona, Spain

Education

Medical School
University of Valencia School of Medicine
Residency
Morristown Memorial Hospital
Fellowship
Baylor College of Medicine

Areas of Interest

Clinical Interests

His clinical interests are general cardiology, preventive cardiology, echocardiography, and cardiovascular innovations in medicine. He conducts one of the largest and most comprehensive courses in preventive cardiology in the United States, which has been held annually for over 32 years.

Research Interests

Currently he is investigating how to optimize medical and surgical therapies for patients with coronary artery disease and type 2 diabetes and cardiovascular disease prevention.